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Abstract 
Background: Surveying regional cancer incidence and mortality provides significant data that can assist in making 
health policy for local areas; however, the province‑ and region‑based cancer burden in China is seldom reported. In 
this study, we estimated cancer incidence and mortality in Guangdong Province, China and presented basic informa‑
tion for making policies related to health resource allocation and disease control.
Methods: A log‑linear model was used to calculate the sex‑, age‑, and registry‑specific ratios of incidence to mortal‑
ity (I/M) based on cancer registry data from Guangzhou, Zhongshan, and Sihui between 2004 and 2008. The cancer 
incidences in 2009 were then estimated according to representative I/M ratios and the mortality records from eight 
death surveillance sites in Guangdong Province. The cancer incidences in each city were estimated by the corre‑
sponding sex‑ and age‑specific incidences from cancer registries or death surveillance sites in each area. Finally, the 
total and region‑based cancer incidences and mortalities for the entire population of Guangdong Province were 
summarized.
Results: The estimated I/M ratios in Guangzhou (3.658), Zhongshan (2.153), and Sihui (1.527) were significantly dif‑
ferent (P < 0.001), with an average I/M ratio of 2.446. Significant differences in the estimated I/M ratios were observed 
between distinct age groups and the three cancer registries. The estimated I/M ratio in females was significantly 
higher than that in males (2.864 vs. 2.027, P < 0.001). It was estimated that there were 163,376 new cancer cases 
(99,689 males and 63,687 females) in 2009; it was further estimated that 115,049 people (75,054 males and 39,995 
females) died from cancer in Guangdong Province in 2009. The estimated crude and age‑standardized rate of inci‑
dences (ASRI) in Guangdong Province were 231.34 and 246.87 per 100,000 males, respectively, and 156.98 and 163.57 
per 100,000 females, respectively. The estimated crude and age‑standardized rate of mortalities (ASRM) in Guangdong 
Province were 174.17 and 187.46 per 100,000 males, respectively, and 98.59 and 102.00 per 100,000 females, respec‑
tively. In comparison with the western area and the northern mountain area, higher ASRI and ASRM were recorded in 
the Pearl River Delta area and the eastern area in both males and females.
Conclusions: Cancer imposes a heavy disease burden, and cancer patterns are unevenly distributed throughout 
Guangdong Province. More health resources should be allocated to cancer control, especially in the western and 
northern mountain areas.
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Background
Cancer is the leading cause of death in China [1–4]. Ana-
lyzing the cancer burden in a population can provide 
valuable information for collecting etiological data and 
developing cancer control policies. In China, social and 
economic changes and an aging population have con-
tributed to rapid increases in the morbidity and mortal-
ity of most cancers. It has been observed that different 
provinces/areas in China have uneven trends in cancer 
development because of special risk factors [5, 6]. Thus, 
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surveying regional cancer incidence and mortality trends 
can provide valuable data to assist in making health pol-
icy for local areas. The National Central Cancer Registry 
has published Chinese national cancer incidence and 
mortality statistics since 2008 [7]; however, the province- 
and region-based cancer burden is rarely reported.
Guangdong Province has a highly developed economy 
and a population of approximately 100 million; however, 
the level of economic development varies throughout the 
province. The Pearl River Delta area (including Guang-
zhou, Shenzhen, Zhuhai, Foshan, Zhongshan, Dongguan, 
Huizhou, Zhaoqing, and Jiangmen), which is a floodplain 
in the center of Guangdong Province, and the eastern 
area (including Shantou, Chaozhou, Jieyang, and Shan-
wei) of Guangdong Province are economically well devel-
oped (i.e., average income), industrialized, populous, 
and polluted. In comparison, in the northern mountain 
area (including Shaoguan, Qingyuan, Meizhou, Heyuan, 
and Yunfu) and the western area (including Zhanjiang, 
Maoming, and Yangjiang) of the province, the level of 
economic development is lower, and the population is 
sparse, but the environmental pollution is lower. Dif-
ferences in population, economy, industrialization, and 
lifestyle in various areas of Guangdong Province may 
influence the risk of cancer.
No provincial cancer incidence data exist for Guang-
dong Province up to now, which limits the evidence avail-
able for making cancer control policies. Since 1997, four 
cancer registry sites have been established in Guangdong 
Province. These sites cover a population of approxi-
mately 20 million, including two big cities (Guangzhou 
and Shenzhen) and two medium-sized cities (Zhongshan 
and Sihui); however, these cities are concentrated in the 
Pearl River Delta area. The uneven distribution of cancer 
registry sites means that the cancer registry data cannot 
depict a representative picture of the provincial cancer 
burden. Recently, three new cancer registry sites were 
built in Guangdong Province, but they lack precision and 
completeness with the cancer incidence too low or the 
incidence-to-mortality (I/M) ratio extremely high. Fortu-
nately, eight death surveillance sites in Guangdong Prov-
ince are distributed in more areas, including the northern 
mountain, western, and eastern areas of the province. 
Estimating the incidence and mortality of cancer using 
combined data from the cancer registries and death sur-
veillance sites in Guangdong Province will provide more 
accurate data.
Jensen et  al. [8] developed a statistical technique for 
estimating the incidence of cancer using mortality data. 
They used a model of mortality as a Poisson regression 
with the log incidence as an offset to estimate the inci-
dence of cancer based on the number of cancer deaths. 
This model has been applied comprehensively to estimate 
the cancer burden in European and other countries [2, 9, 
10]. Chen et al. [11] used a generalization of this method 
to estimate the cancer burden in China. They fitted gen-
eralized linear mixed models and estimated the param-
eters of models by a Bayesian Markov chain Monte Carlo 
method. In the present study, we estimated the total and 
regional cancer burden in Guangdong Province in 2009 





Since 1997, four cancer registry sites have existed in 
Guangzhou, Shenzhen, Zhongshan, and Sihui in Guang-
dong Province. We collected incidence and mortality 
data between 2004 and 2008 from each registry site. After 
evaluating the quality of the cancer registries according 
to the standards defined by the International Agency for 
Research on Cancer [12], we determined that the com-
pleteness and reliability of mortality data from Shenz-
hen did not meet the standards; therefore, the data from 
Shenzhen were excluded from the development of an 
estimation model for the I/M ratio. Thus, data from three 
cancer registries were included in the estimation model. 
The reported cancer spectrum in the cancer registries 
contained all types of cancer (ICD-10 C00-C90).
Cancer mortality data were collected from the Guang-
dong Provincial Center of Disease Control and Preven-
tion. The data were from eight death surveillance sites 
in Guangdong Province, located in the Yuexiu district of 
Guangzhou, Zhuhai, Taishan, Nanxiong, Yunfu, Shan-
wei, Sihui, and Wuhua. The mortality data from Yuexiu 
of Guangzhou and Sihui overlapped the data from the 
cancer registries. Therefore, only one set of data was 
included in the analysis (Table 1).
Population data
Population and age distribution data were obtained 
from the Guangdong statistics annual report, published 
by the Guangdong Statistics Bureau [13]. The estimated 
provincial population in 2009 was 83,659,800, includ-
ing 43,091,000 males and 40,568,800 females. Regional 
population data in 2009 were extracted by sex and age 
(grouped into 5-year age ranges, e.g., 0–4, 5–9, 10–14, 
… 80–84, and 85+  years). The estimated populations 
were 29,670,200 in the Pearl River Delta area, 17,583,400 
in the eastern area, 17,741,200 in the western area, and 
18,665,000 in the northern mountain area [13].
Statistical methods
Since the I/M ratio is a fairly stable value in a large, 
defined population, it is used as an index to evaluate the 
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quality of cancer registry data. Furthermore, it can be 
used to estimate cancer incidence and mortality for the 
same population [10, 11]. In our study, we estimated can-
cer incidence in different parts of Guangdong Province 
using the combination of mortality and the I/M ratio. 
The I/M ratios were estimated from log-linear models of 
the number of incident cases based on the aggregation 
of cancer registries in Guangzhou, Zhongshan, and Sihui 
between 2004 and 2008, offset by the number of deaths 
in the same registries and adjusted for sex and age. The 
regional incidence number (IN) in 2009 were obtained 
by applying a set of sex-, age-, city-specific I/M ratios and 
the estimated regional mortality number (MN) as follows: 
IN = MN × (I/M). Before aggregation, each registry was 
weighted to account for the relative size of the population.
A log-linear regression model was developed for each 
sex. The age groups were indexed by i (i = 1, …, 18), and 
the registries were indexed by j (j = 1, 2, 3). The I/M ratio 
was expressed as the log(I/M) = µj + βi, where βi repre-
sents the log of the mean age-specific I/M ratio, and μj 
represents the random intercept for different registries. 
Then, the regional incidence was estimated by using the 
formula exp (μj + βi) ×  mortality in each age group in 
each area.
For each city in Guangdong Province that was studied, 
the number of cancer cases and deaths in 2009 were esti-
mated by multiplying the predicted incidence and mor-
tality by the corresponding city populations. The cancer 
registry and death surveillance sources for the estimated 
incidences and mortalities in the cities in Guangdong are 
listed in Table 1. The rates were calculated by using the 
age-standardized rate per 100,000, based on the standard 
population of China in 2000.
We were authorized to use the data from the cancer 
registry and death surveillance sites for this analysis. 
No personal information, such as name, identification 
number, home address, and personal contact details, 
was included when the analyzed data were extracted 
from the database. Given the highly aggregated form of 
data extraction, ethics approval was not required for this 
study.
Results
The I/M ratios for cancers in Guangdong Province
Based on the cancer incidence and mortality data from 
the three cancer registries (Guangzhou, Zhongshan, 
and Sihui) between 2004 and 2008, the estimated aver-
age I/M ratio was 2.446 [95% confidence interval (CI) 
2.324–2.568]. The sex- and registry site-adjusted I/M 
ratios are shown in Table 2. Males had a lower I/M ratio 
than females (2.027, 95% CI 1.856–2.199 in males and 
2.864, 95% CI 2.691–3.038 in females). The I/M ratio in 
Guangzhou (3.658, 95% CI 3.457–3.859) was the highest; 
the I/M ratio in Sihui (1.527, 95% CI 1.294–1.759) was 
the lowest. The age-specific I/M ratio showed an overall 
declining trend in males and females (Fig.  1); however, 
the age-specific I/M ratio in males reached a plateau after 
the 55- to 60-year age range and approached the level of 
I/M ratio in females.
Table 3 shows the I/M ratios of cancers in the three cit-
ies in 2009. A log-linear regression model was used to 
Table 1 The economic partitions and covered areas of the 
cancer registry and  death surveillance data sources 
in Guangdong Province, China
Economic area City Cancer registry Death surveillance 
site























Table 2 The I/M ratios from  the three cancer registries 
in Guangzhou, Zhongshan, and Sihui in Guangdong Prov-
ince, China in 2004–2008





 Male 2.027 0.087 1.856–2.199
 Female 2.864 0.088 2.691–3.038
City
 Guangzhou 3.658 0.102 3.457–3.859
 Zhongshan 2.153 0.101 1.953–2.352
 Sihui 1.527 0.118 1.294–1.759
Average 2.446 0.062 2.324–2.568
Page 4 of 8Cao et al. Chin J Cancer  (2015) 34:58 
estimate the corresponding cancer incidences in six cit-
ies (Zhuhai, Taishan, Nanxiong, Wuhua, Shanwei, and 
Yunfu) by using the local death surveillance data and the 
I/M ratios from Sihui or Zhongshan (Table 4).
Estimated cancer incidence and mortality in Guangdong 
Province
Cancer incidence data from three cancer registries and 
cancer mortality data from six death surveillance sites 
were used to estimate the cancer incidences of the 21 
cities in Guangdong Province and then to aggregate the 
cancer burden in the four economic areas and in the 
entire province. The cancer incidences in the four areas 
and the entire Guangdong Province in 2009 are shown 
in Table  5. The estimated total new cases of cancer in 
2009 was 163,376, including 60,352 in the Pearl River 
Delta area, 39,796 in the eastern area, 30,679 in the west-
ern area, and 32,550 in the northern mountain area. The 
estimated crude incidence and age-standardized rate of 
incidence (ASRI) of cancer were 231.34 and 246.87 per 
100,000 males, respectively, and 156.98 and 163.57 per 
100,000 females, respectively. In the four economic areas 
of Guangdong Province, the ASRI in males was the high-
est in the eastern area (307.29 per 100,000), followed 
by the Pearl River Delta area (269.04 per 100,000) and 
the western area (212.51 per 100,000); it was the lowest 
in the northern mountain area (206.19 per 100,000). In 
comparison, the highest ASRI of cancer in females was 
208.81 per 100,000 in the Pearl River Delta area, followed 
by 192.26 per 100,000 in the eastern area, 120.39 per 
100,000 in the western area, and 115.25 per 100,000 in 
the northern mountain area.
Fig. 1 The estimated age‑specific ratios of cancer incidence to 
mortality in males and females in three cities (Guangzhou, Zhong‑
shan, and Sihui) using a log‑linear regression model in Guangdong 
Province, China. °, mean of ratio; , 95% confidence interval
Table 3 The I/M ratio in Guangzhou, Zhongshan, and Sihui, China in 2009 (per 100,000)
CI crude incidence, ASRI age-standardized rate of incidence, CM crude mortality, ASRM age-standardized rate of mortality
City Males Females
CI ARSI CM ASRM I/M CR ASRI CM ASRM I/M
Guangzhou 355.86 273.87 252.81 188.30 1.41 301.64 213.48 155.61 98.38 1.94
Zhongshan 243.47 207.74 176.01 150.22 1.38 156.78 122.47 80.43 61.19 1.95
Sihui 266.38 284.30 189.26 203.18 1.41 190.09 164.65 99.50 82.37 1.91
Table 4 The mortalities and estimated incidences of cancers in Zhuhai, Taishan, Nanxiong, Wuhua, Shanwei, and Yunfu 
in Guangdong Province, China in 2009 (per 100,000)
Abbreviations as in Table 3
a The incidence was estimated using the I/M ratio of Zhongshan
b The incidence was estimated using with the I/M ratio of Sihui
City Males Females
CR ASRI CM ASRM CR ASRI CM ASRM
Zhuhaia 129.88 138.54 98.65 104.49 123.12 128.77 66.15 68.42
Taishana 200.34 160.82 151.87 116.04 127.77 109.92 66.81 52.09
Nanxiongb 180.63 182.25 147.96 148.80 118.20 102.62 78.43 63.39
Wuhuab 162.54 178.94 134.80 146.42 89.62 94.70 61.71 62.32
Shanweia 194.89 270.15 152.64 209.99 117.65 158.80 74.02 91.38
Yunfub 159.23 189.31 133.60 158.73 109.95 103.69 77.09 67.77
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Table 6 shows the estimated crude mortality and age-
standardized rate of mortality (ASRM) of cancer in the 
four economic areas and in the entire Guangdong Prov-
ince in 2009, including 37,539 in the Pearl River Delta 
area, 28,566 in the eastern area, 23,857 in the west-
ern area, and 25,088 in the northern mountain area. It 
was estimated that 115,049 people died from cancer 
in Guangdong in 2009. The crude mortality and ASRM 
were 174.17 and 187.46 per 100,000 males, respectively, 
and 98.59 and 102.00 per 100,000 females, respectively. 
Just like the distribution of cancer incidence, the ASRM 
of cancer in males was the highest in the eastern area of 
the province (238.69 per 100,000), but the ASRM of can-
cer in the Pearl River Delta area was close to that in other 
areas, with 177.98 per 100,000 in the delta area, 170.55 
per 100,000 in the western area, and 168.91 per 100,000 
in the northern mountain area. The highest ASRM of 
cancer in females was 126.78 per 100,000 in the Pearl 
River Delta area, followed by 113.75 per 100,000 in the 
eastern area, 79.36 per 100,000 in the western area, and 
75.15 per 100,000 in the northern mountain area.
The age distributions of cancer incidence and mortality
Figure  2 shows the age-specific rates of cancer inci-
dence and mortality curves in Guangdong Province. 
In males, the age-specific rates of cancer incidence 
and mortality increased sharply after 30  years of age 
and reached a peak at 75–80  years of age. In females, 
the incidence and mortality had two peaks: one minor 
peaked around age 50–55  years and then declined in 
the subsequent 5–10 year group ranges; thereafter, can-
cer incidence and the mortality increased again until 
age 75–80 years.
Discussion
In this study, we estimated the total I/M ratio of cancers 
in Guangdong Province in 2009 using a log-linear model 
based on the aggregation of cancer registry and death 
surveillance data. The population involved in the cancer 
registries and death surveillance sites was 12.86 million, 
encompassing 15.4% of the total population of Guang-
dong [13]. The death surveillance sites were distributed 
in all areas of Guangdong, which made the estimation 
more representative and precise. Owing to the difference 
in the I/M ratios among different sex and age groups, we 
also used sex- and age-specific parameters in the model. 
Therefore, the estimation reflects the realistic cancer bur-
den in Guangdong Province and provides valuable infor-
mation for developing cancer prevention and control 
policies.
Table 5 The estimated incidences of  cancers in  different economic areas of  Guangdong Province, China in  2009 (per 
100,000)
ASRI age-standardized rate of incidence
Age Pearl River Delta area Eastern area Western area Northern mountain area Total
Males Females Males Females Males Females Males Females Males Females
0– 13.12 11.42 0.00 0.00 1.52 0.00 22.33 16.33 9.89 7.52
5– 11.10 4.83 14.44 0.00 3.00 0.00 6.07 0.00 8.45 1.29
10– 9.31 8.87 4.99 18.03 1.13 1.28 11.44 4.73 6.29 8.83
15– 16.11 14.17 43.48 0.00 12.99 3.32 12.15 13.07 21.32 7.85
20– 20.95 20.98 20.21 0.00 18.47 3.49 16.77 5.03 19.68 11.15
25– 31.55 33.29 0.00 25.20 13.06 63.40 20.22 28.24 20.47 35.80
30– 43.70 59.68 34.92 22.64 77.84 28.93 45.27 39.51 48.42 43.69
35– 100.40 121.47 144.97 194.75 108.40 66.72 127.02 66.20 115.16 113.35
40– 199.18 215.82 148.53 88.37 112.35 211.18 187.21 102.58 171.00 164.52
45– 261.48 285.85 310.29 88.25 245.70 120.84 282.85 195.39 273.03 191.04
50– 495.54 430.46 549.58 618.31 355.78 220.15 324.67 191.34 433.34 366.45
55– 844.85 609.30 970.50 793.85 534.70 371.16 577.29 332.40 734.95 534.29
60– 909.10 551.38 1332.26 318.87 661.70 124.18 690.18 279.68 880.88 347.81
65– 1126.07 610.51 1290.79 500.86 603.24 241.37 756.13 347.44 916.73 430.15
70– 1440.00 879.27 1726.85 611.40 1466.52 405.04 1278.88 471.72 1457.02 601.42
75– 1621.16 899.10 1847.73 1274.01 1719.95 914.12 970.90 577.31 1513.55 882.38
80– 1785.34 981.55 1498.50 1085.43 1829.40 946.54 899.74 495.86 1514.33 858.71
85– 1643.92 730.28 673.23 491.75 661.96 525.41 414.23 392.00 852.96 541.65
Total 221.16 185.01 276.29 174.36 215.33 125.00 221.12 124.79 231.34 156.98
ASRI 269.04 208.81 307.29 192.26 212.51 120.39 206.19 115.25 246.87 163.57
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It has been reported that the I/M ratios of cancers 
differ significantly in different registries, sexes, and 
age groups [9, 10]. Indeed, our results, based on data 
from three cancer registry sites, showed that the aver-
age I/M ratios in Guangzhou, Zhongshan, and Sihui 
were clearly distinguished. The I/M ratio in Guangzhou 
was the highest, followed by Zhongshan; Sihui had the 
lowest I/M ratio. The estimated I/M ratio was consist-
ent with the regional economic development level and 
health resources. Guangzhou is the capital of Guangdong 
Province and congregated high-level general hospitals 
and tumor hospitals. High quality of health service may 
result in a higher average I/M ratio in Guangdong (2.466) 
than in the country as a whole (1.35) [9]. Therefore, the 
I/M ratio in Guangzhou is not suitable for other cities in 
Guangdong Province. We used the I/M model of Zhong-
shan to estimate the cancer incidence in medium-sized 
cities, such as Zhuhai, Taishan, and Shanwei; we used the 
I/M model of Sihui to estimate the cancer incidence in 
other cities.
With increasing age from 30 years until 85 years old, the 
I/M ratio of cancer decreased in both males and females. 
The trend in females was almost linear; however, there 
was a plateau in males at 40–60  years of age. The high 
incidences and mortalities of liver and lung cancer in this 
age range of males may explain the results. The results 
showed that the estimated crude cancer incidences in 
Guangdong Province were 231.34 per 100,000 males and 
156.98 per 100,000 females in 2009, with 163,376 new 
cancer cases occurring annually (99,689 males and 63,687 
females). These crude cancer incidences in Guangdong 
Province are higher than the nationwide average and 
close to the incidences in urban areas throughout the 
entire country [9].
According to the areal relationship and economic 
developing level, Guangdong Province was divided into 
four economic areas, including the eastern area, the Pearl 
River Delta area, the western area, and the northern 
mountain area. We analyzed the cancer incidences and 
mortalities in these areas. Higher cancer incidence and 
mortality in males and females were observed in the east-
ern area and the Pearl River Delta area; lower rates were 
observed in the western area and the northern mountain 
area. The higher cancer incidences and mortalities in the 
eastern area and the Pearl River Delta area may be related 
to a higher level of urbanization and industrialization, 
which brought more carcinogenetic contaminants to the 
environments.
From our results, the total numbers of cases and death 
in the eastern, western, and northern mountain areas 
Table 6 The estimated mortalities of  cancers in  different economic areas of  Guangdong Province, China in  2009 (per 
100,000)
ASRM age-standardized rate of mortality
Age Pearl River Delta area Eastern area Western area Northern mountain area Total
Males Females Males Females Males Females Males Females Males Females
0– 5.21 6.80 0.00 0.00 0.75 0.00 16.74 8.99 6.09 4.29
5– 5.67 3.63 8.40 0.00 1.75 0.00 4.82 0.99 5.03 1.21
10– 8.45 7.80 4.60 5.41 1.04 0.39 9.08 3.55 5.45 4.32
15– 5.82 6.25 19.87 0.00 7.77 0.70 10.98 7.38 10.90 3.62
20– 6.19 8.79 8.30 0.00 9.31 1.41 10.80 3.46 7.91 4.88
25– 9.26 15.72 0.00 5.80 5.66 21.33 11.20 11.94 7.22 14.02
30– 20.81 29.97 18.36 5.97 47.44 9.85 31.68 15.76 27.06 19.35
35– 47.01 52.94 75.15 59.79 63.78 28.77 88.88 29.71 63.51 44.92
40– 97.10 90.77 92.67 28.40 75.20 98.83 142.90 67.68 103.05 75.23
45– 162.91 157.63 230.28 30.77 184.65 54.72 215.79 92.11 193.40 95.53
50– 317.51 250.32 414.08 298.40 284.21 136.06 278.01 96.07 321.12 197.83
55– 458.97 308.95 712.36 384.62 402.50 221.60 448.14 189.66 499.05 278.86
60– 570.33 347.89 1017.34 194.23 509.02 81.79 535.89 212.79 639.45 227.67
65– 829.67 436.28 1024.43 339.64 500.55 181.18 667.70 269.46 735.36 312.09
70– 1066.07 667.73 1459.35 490.20 1264.56 338.32 1125.39 418.52 1210.05 485.95
75– 1426.58 704.78 1787.77 1226.99 1664.11 882.32 939.36 482.03 1427.64 782.72
80– 1523.39 711.60 1568.15 1054.71 1727.52 861.73 794.34 438.30 1405.02 739.10
85– 1595.98 651.34 845.07 704.85 695.05 595.55 370.01 337.05 873.45 566.12
Total 142.57 109.88 215.93 106.86 177.17 86.23 181.98 83.92 174.17 98.59
ASRM 177.98 126.78 238.69 113.75 170.55 79.38 168.91 75.15 187.46 102.00
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accounted for more than 60% of all cancer cases in Guang-
dong in 2009. At present, cancer treatment resources are 
focused mainly on the Pearl River Delta area of Guang-
dong, especially Guangzhou and Shenzhen. This reflected 
that health resources distributed imbalance in Guangdong 
Province. We recommend that the allocation of medical 
resources and cancer treatment levels should be improved 
in the eastern, western, and northern mountain areas.
Our study showed that the estimated age-specific rates 
of cancer incidences and mortalities in Guangdong Prov-
ince in 2009 increased monotonically with increasing 
age in males. However, in females, the age-specific rates 
of cancer incidences and mortalities had two peaks: one 
minor peaked around ages 50–55 years and then declined 
in the subsequent 5–10  year group ranges; thereafter, 
the cancer incidence and mortality increased again until 
ages 75–80  years. We suppose that this may be caused 
by an early exposure to common carcinogenic agents in 
females. For example, it has been reported that breast 
cancer, which is one of the most common cancers in 
Chinese women, has an earlier age of onset in Chinese 
women compared with women in Western countries 
[14]. This may be due to lifestyle differences in early life 
and differences of genetic background [15].
There are some limitations in this study. First, we only 
focused on the whole cancer burden in the dimension of 
cancer incidence and mortality and not to explore other 
dimension, such as cost of cancer treatment. Second, 
there is usually a 3-year delay in the publication of cancer 
registry data in China; therefore, we could use the data 
between 2004 and 2008 only to build the model of I/M 
ratio estimation and to estimate the incidence in 2009. 
In the future, more comprehensive and long-term cancer 
data should be collected, including cancer incidences and 
mortalities and survival data, so that more detailed and 
precise cancer burden analysis can be performed.
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